While our study provides valuable insights into the association between RB1 and TP53 mutations and SCLC transformation in the context of NSCLC with driver gene positivity, we acknowledge the limitation posed by the relatively small sample size of seven patients in our cohort. Here, TP53 is linked to non-small cell lung carcinoma.